Phreesia Inc

Phreesia, Inc. is a healthcare software company, which engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Phreesia reports strong Q1 earnings, sees growth in Medicare market

Phreesia's Q1 2023 earnings call highlighted strong performance, maintained revenue outlook, and raised adjusted EBITDA outlook. The company faces challenges from labor market changes and pricing experimentation but sees opportunities in product growth, client adds, and patient insights application.

Phreesia reports strong Q2 2024 earnings and strategic acquisitions

Phreesia's Q2 2024 performance reflects strong revenue growth and strategic outlook, despite challenges related to client adds and subscription revenue. The company's focus on achieving profitability beyond fiscal 2025 and strategic acquisitions positions it for long-term value creation. Balancing growth and investment, as well as navigating seasonality and external events, are key considerations for Phreesia's future.

Phreesia reports Q3 2024 revenue of $91.6 million, delays revenue target to prioritize EBITDA growth

Phreesia's Q3 2024 earnings call highlighted strong revenue performance, an acquisition enhancing patient experience, and a strategic decision to delay revenue targets to prioritize EBITDA growth. The company maintains a focus on innovation, customer satisfaction, and sustainable financial performance, while also addressing short-term financial challenges and positioning for significant revenue and profitability growth in fiscal 2025.

Phreesia reports robust Q4 earnings, eyes growth in healthcare solutions

Phreesia Inc's Q4 2023 performance reflects strong revenue growth and client base expansion, positioning the company for future profitability and stability.
With a focus on client value, strategic acquisitions, and operational efficiency, Phreesia navigates challenges in the healthcare industry to drive long-term growth.
Opportunities in network solutions, payer space, and margin improvement present avenues for Phreesia to capitalize on market trends and enhance shareholder value.

Phreesia Inc reports strong Q1 earnings, eyes revenue growth

Phreesia Inc's Q1 2024 performance reflects robust revenue growth and client expansion, with a positive outlook for fiscal 2024 and ambitious targets for fiscal 2025.
While facing challenges such as potential growth deceleration and labor market impacts, the company remains focused on innovation, client satisfaction, and profitability.
Opportunities in new revenue streams, partnerships, and payment technologies present avenues for Phreesia to drive future growth and market leadership.

Phreesia Inc reports robust Q2 performance and targets fiscal growth

Phreesia Inc's Q2 2024 earnings call highlighted strong revenue growth, improved EBITDA, and strategic targets for fiscal 2024 and 2025, underpinned by investments in client value and growth strategies.
While facing challenges in the sales cycle and cost controls, the company remains focused on achieving profitability and free cash flow without additional capital beyond fiscal '25.
Opportunities in product introductions, customer service enhancements, and market expansion present avenues for sustained growth and value creation for Phreesia.

Phreesia reports robust Q3 performance, shifts focus to profitability

Phreesia Inc's Q3 2024 earnings call highlighted strong revenue growth, improved EBITDA, and strategic acquisitions, underlining the company's positive trajectory.
While facing challenges in achieving profitability and managing investor expectations, Phreesia's focus on financial discipline and market expansion presents opportunities for sustainable growth.
The establishment of a new credit facility and clear guidance for fiscal 2024 and 2025 demonstrate Phreesia's commitment to financial stability and long-term value creation.

Phreesia reports strong Q4 revenue growth and focuses on profitability

Phreesia Inc's Q4 performance reflects revenue growth and improved EBITDA, with a focus on efficiency and client value to drive profitability.
Despite industry challenges, Phreesia's strengths in client growth strategies, network solutions revenue, and cash flow support its growth trajectory.
Balancing profitability goals with investments in growth, Phreesia navigates challenges while exploring opportunities in PAM, client value, and network expansion.
The company's outlook for FY 2025 underscores a commitment to sustainable growth through client additions, product enhancements, and operational efficiency.

Phreesia Inc reports strong Q1 earnings, eyes growth opportunities

Phreesia Inc's Q1 performance reflects a positive turnaround with revenue growth and adjusted EBITDA turning positive after 3 years. The company faces challenges from client relationship transitions but is leveraging opportunities in cybersecurity investments and revenue-driving products.

Phreesia Inc reports robust Q2 earnings and optimistic outlook

Phreesia Inc's Q2 2025 earnings call highlighted strong financial performance and positive outlook for fiscal 2025. While facing uncertainties around external factors and inorganic opportunities, the company remains focused on driving growth through AHSC expansion and revenue enhancement strategies.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.

Levi & Korsinsky Investigates Possible Securities Fraud Violations by Phreesia, Inc. (PHR)

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is pleased to announce that it has named Bob Glazer as the company's Strategic Advisor.

Bob Glazer Joins Phreesia as Strategic Advisor

NEW YORK, NY / ACCESSWIRE / August 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.

An Investigation Has Commenced on Behalf of Phreesia, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your PHR Losses.

Lost Money on Phreesia, Inc.(PHR)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky

NEW YORK, NY / ACCESSWIRE / August 1, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.

ATTENTION Phreesia, Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it will release its fiscal second quarter 2025 financial results after the close of market trading on Sept. 4, 2024.

Phreesia Sets Release Date for Fiscal Second Quarter 2025 Results

NEW YORK, NY / ACCESSWIRE / July 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.

PHR STOCK ALERT: Levi & Korsinsky Notifies Phreesia, Inc. Investors of an Ongoing Investigation

WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia is now available on the Oracle Healthcare Marketplace and can be integrated with the Oracle Health Electronic Health Record (EHR).

Phreesia Now Available on Oracle Healthcare Marketplace

NEW YORK, NY / ACCESSWIRE / July 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.

An Investigation Has Commenced on Behalf of Phreesia, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your PHR Losses

NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.

Investors who Lost Money on Phreesia, Inc. Should Contact Levi & Korsinsky About an Ongoing Investigation - PHR

The average of price targets set by Wall Street analysts indicates a potential upside of 27.8% in Phreesia (PHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wall Street Analysts Think Phreesia (PHR) Could Surge 27.77%: Read This Before Placing a Bet

NEW YORK, NY / ACCESSWIRE / July 14, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ("Phreesia" or the "Company") (NYSE:PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHR

Phreesia (PHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Phreesia (PHR) Upgraded to Strong Buy: Here's What You Should Know

NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. – PHR

NEW YORK , July 10, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Phreesia, Inc. ("Phreesia" or the "Company") (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Phreesia, Inc. - PHR

NEW YORK, NY / ACCESSWIRE / July 5, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.

Lost Money on Phreesia, Inc. (PHR)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky

PHR ALERT - Levi & Korsinsky Has Commenced an Investigation on Behalf of Phreesia, Inc. Shareholders Who Lost Money

NEW YORK, NY / ACCESSWIRE / July 2, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.

Phreesia, Inc. (PHR) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates

Levi & Korsinsky Reminds Phreesia Investors of the Ongoing Investigation into Potential Violations of Securities Laws - PHR

NEW YORK, NY / ACCESSWIRE / June 30, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.

Lost Money on Phreesia, Inc.(PHR)? Contact Levi & Korsinsky Regarding an Ongoing Investigation

NEW YORK, NY / ACCESSWIRE / June 28, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.

ATTENTION PHR SHAREHOLDERS: Investors who lost money on Phreesia, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation

Applied DNA Sciences

Biodesix

Vigil Neuroscience

Clear Secure

Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include CLEAR Secure (YOU), Applied DNA Sciences (APDN), Phreesia (PHR), Vigil Neuroscience (VIGL) and Biodesix (BDSX).

Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E

Enovis Corp

Hims & Hers Health

Standard BioTools Inc

Pulmonx

We have narrowed our search to five medical info systems stocks. These are: HIMS, ENOV, LUNG, PHR, LAB.

5 Medical Info Systems Stock to Buy for a Stable Portfolio

NEW YORK, NY / ACCESSWIRE / June 20, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. ("Phreesia" or "the Company") (NYSE:PHR). Investors who purchased Phreesia securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PHR.

Phreesia, Inc. (PHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia partners with the National Kidney Foundation and shares new research on early diagnosis and treatment of kidney disease.

News for Phreesia Inc Stock (PHR)